Waters Corporation (N:WAT)

Business Focus: Advanced Medical Equipment & Technology

Sector:  Healthcare Industry:  Advanced Medical Equipment & Technology
 
See Regulatory Filings on SEC
Company Contact
Address: 34 MAPLE ST
MILFORD MA 01757-3604
Tel: 1-508-4823448
Website: www.waters.com
IR: See website
<
Key People
Christopher J. O'Connell
Chairman of the Board, President, Chief Executive Officer
Sherry L. Buck
Chief Financial Officer, Senior Vice President
Keeley A Aleman
Senior Vice President, General Counsel and Corporate Secretary
Elizabeth B. Rae
Senior Vice President - Global Human Resources
Robert G. Carson
Senior Vice President - Corporate Development
Michael C. Harrington
Senior Vice President - Global Markets
Francis S Kim
Senior Vice President - Global Operations
Ian S. King
Senior Vice President - Global Products
Jonathan M. Pratt
Senior Vice President and President of TA Instruments
Business Overview
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans. It also designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments through its TA product line. It is also a developer and supplier of software-based products that interface with the Company's instruments, as well as other suppliers' instruments. Its LC and LC-MS instruments are utilized in a range of industries to detect, identify, monitor and measure the chemical, physical and biological composition of materials, and to purify a range of compounds.
Financial Overview
For the nine months ended 28 September 2019, Waters Corporation revenues decreased 1% to $1.69B. Net income before extraordinary items decreased 6% to $388.3M. Revenues reflect United States segment decrease of 17% to $487.3M, Europe segment decrease of 7% to $428.1M. Net income also reflects Interest income decrease of 38% to $17.6M (income), Purchased intangibles amortization increase of 33% to $7.2M (expense).
Employees: 7,200 as of Dec 31, 2018
Reporting Currency: U.S. Dollars
Enterprise value: $15,365M as of Sep 28, 2019
Annual revenue (TTM): $2,405M as of Sep 28, 2019
EBITDA (TTM): $831.66M as of Sep 28, 2019
Net annual income (TTM): $568.89M as of Sep 28, 2019
Free cash flow (TTM): $490.67M as of Sep 28, 2019
Net Debt Last Fiscal Year: $951.01M as of Sep 28, 2019
Shares outstanding: 64,434,377 as of Oct 25, 2019
Index Membership: S&P 500
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization